- Lecture presentation
- Open Access
Medical treatment of actinic keratoses and superficial skin cancers: diclofenac
- G Valenti1
© Valenti; licensee BioMed Central Ltd. 2010
- Published: 19 May 2010
- Hyaluronic Acid
- Skin Cancer
- Clinical Case
- Conventional Therapy
- Patient Compliance
In patients who develop early signs of fotocarcinogenesi, the actinic keratosis are one of the most frequent events that can lead to problems of therapeutic management, especially if for business reasons or lifestyle, they are repeatedly and chronically exposed to the sun. In these patients the lesions are often widespread and recurrent, and may require repeated treatment cycles.
It is in these cases that treatment with topical diclofenac 3% gel hyaluronic acid can provide good results thanks to its efficacy, tolerability, the patient compliance and excellent cosmetic results compared to other conventional therapies.
It presents a brief review of clinical cases with the treatment modality and they discuss the indications and efficacy.
This article is published under license to BioMed Central Ltd.